Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented the lead investors in the transaction. Sakana AI, a Japan-based AI research and development company, announced raising $100...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP recently represented New Enterprise Associates, Inc. as lead investor. Comanche Biopharma closed its $75 million Series B financing. New Enterprise Associates, Inc. acted...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented New Enterprise Associates, Inc. on the matter. Fizz, the Gen Z-founded social media platform exclusively available for college students, raised $25...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented NEA in the transaction. Orby AI closed its latest funding round, led by NEA. NEA was joined by Pear VC, as well as...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented New Enterprise Associates (NEA) in the transaction. LXA announced it raised US$10 Million in seed funding, the round...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Versant Ventures and New Enterprise Associates on the deal. Nexo Therapeutics (Nexo) announced it has emerged from stealth with $60 million...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the syndicate of investors on the deal. Tagworks Pharmaceuticals BV announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented NEA on the deal. NEA acted as lead investor in the $19 million seed and Series A funding round for Slash,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Kindred on the deal while Foley & Lardner LLP advised NEA. Kindred, a members-only home swapping network, announced its $15 million Series A financing....
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented New Enterprise Associates, Inc. on the deal. New Enterprise Associates, Inc. (NEA) acted as the lead investor in the $16.5 million...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented New Enterprise Associates (NEA) on the deal. New Enterprise Associates (NEA) acted the lead investor in the $12 million Series A funding...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised NEA and Abingworth on the transaction. Escient Pharmaceuticals announced that it had raised $120 million through a Series C Financing...
You must be a Standard 1 Year member to access this content.
